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The distribution of y-glutamyl transpeptidase (y-GTP), 
tyrosinase, and 5-S -cysteinyldopa (5-S-CD) within mel-
anoma cells has been studied in vitro as well as in vivo. 
Sodium periodate treatment of intact B -16 melanoma 
cells has been found to inhibit y-GTP present as an 
ectoenzyme. However, these periodate-treated cells in 
the presence of 10-5 M dopa and glutathione have been 
found to continue to secrete large quantities of 5-S-CD 
in their medium. The large-granule fraction of Greene's 
melanotic melanoma contains substantial amounts of 
both tyrosinase and y-GTP. However, further separation 
of the large-granule fraction into sub-fractions indicates 
that tyrosinase and y-GTP seem to co-exist with preme-
lanosome. It is suggested that glutathione-dependent 5-
S-CD genesis proceeds within premelanosomes through 
the formation of glutathione-dopa. The excess of gluta-
thione-dopa and 5-S -CD, unutilized for pheomelanin for-
mation overflow into the cytoplasm. 
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Abbreviations: 
FCS: fetal calf serum 
y-GTP: y-glutamyl transpeptidase 
LGF: large-granule fraction 
MEM: minimum essential medium 
NF: nuclear fraction 
PBS: phosphate-buffered saline 
5-S-CD: 5-S-cysteinyldopa 
SF: soluble frac tion 
SGF: small-granule fraction 
In recent years a large number of sulfur-containing amino 
acids have been discovered to be present in melanin-producing 
cells. Among these 5-S-cysteinyldopa (5-S-CD) is of great in-
terest to biologists and clinicians. This amino acid is believed 
to be the basic building material of pheomelanin and is present 
in substantial quantities in human as well as animal melanomas 
[1,2], and is also excreted in large quantities in the urine by 
metastatic melanoma patients [3]. Two pathways have been 
hypothesized for the synthesis ofthis amino acid within pigment 
cells. One involves the nucleophilic addition of cysteine to 
tyrosinase-catalyzed dopaquinone to form 5-S-CD. The other 
involves the addition of glutathione to dopaquinone to form 
glutathione-dopa, which is then converted to 5-S-CD. Consist-
ent with these two predicted pathways, Ito and Prota [ 4] have 
shown that in the presence of dopa and cysteine, the in vitro 
noncellular mushroom tyrosinase-catalyzed reaction yields 
large quantities of 5-S-CD. Similarly, Rorsman and his group 
[5] have synthesized glutathione-dopa by replacing cysteine 
with glutathione in the mushroom tyrosinase system. Further, 
they [6] have also shown that dialyzed melanoma and kidney 
homogenates are capable of converting glutathione-dopa to 5-
S-CD. 
Our studies on the biosynthetic pathway of 5-S-CD genesis 
in cultured melanoma cells have shown that in the presence of 
dopa and cysteine, media incubated without cells still form 
moderate amounts of 5-S-CD by the a utooxidation of dopa 
[7]. In the presence of dopa and glutathione, only cells contain-
ing media were found to secrete this amino acid. However 
when the concentration · of glutathione was increased to mor~ 
than 1:1 with respect to dopa on the molar basis, there was an 
acute drop in the secretion of 5-S-CD into the medium by these 
melanoma cells. These findings indicate that glutathione-dopa 
is further converted to 5-S -CD within these melanoma cells by 
enzymes involved in the metabolism of glutathione such as y-
glutamyl transpeptidase (y-GTP) . Recently we have found that 
Greene's amelanotic melanoma, which is derived from the 
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melanotic variety during transplantation, is poor in y-GTP and 
tyrosinase activities as compared to the melanotic variety [8]. 
This paper is concerned with the subcellular distribution of y-
GTP in comparison to tyrosinase and 5-S-CD within melanoma 
cells. 
MATERIALS AND METHODS 
Na/0., Treatment of Intact Cells 
B-16 melanoma cells cultured routinely in Eagle's minimum essential 
medium (MEM) and 10% fetal calf serum (FCS) were used. The cells, 
cultured in Petri dishes for 2-3 days, were washed with MEM and 
treated with 1.2 mM NaiO., in phosphate-buffered saline (PBS) for 15 
min at 4 octo inactivate y-GTP present as an ectoenzyme [9]. The cells 
were then washed with MEM and collected with a rubber policeman 
for y-GTP assay. 
5-S-CD Secretion after NaiO, Treatment 
The NaiO,-treated cells were recultured in MEM + 10% FCS alone 
or MEM + 10% FCS supplemented with 10-" M of dopa and glutathione 
for 20 h (7]. The medium was then collected and assayed for its 5-S-CD 
content. The cells were collected as mentioned above and assayed for 
y-GTP. 
Subcellular Fractionation 
Greene's melanotic melanoma (2-3 mm3) was inoculated into the 
flanks of Syrian (golden) hamsters and 2 weeks later the animals were 
sacrificed and the tumors removed. Nuclear (NF), large-granule (LGF), 
small-granule (SGF) , and soluble (SF) fractions were obtained by 
centrifugation according to the methods of Mishima [10]. In some 
experiments melanosomes were purified by resuspending LGF, in 0.25 
M sucrose and layering it over 1.7 M sucrose and centrifuging it at 37,000 
g for 60 min [ll]. The LGF remaining at the interphase of 1.7 and 0.25 
M sucrose, the fraction entering 1.7 M sucrose, and the pellets were 
collected and labeled as LGF 1, 2, and 3, respectively. These fractions 
were stained negatively with 2% phosphotungstic acid and observed 
under the electron microscope. 
Assay Techniques 
5-S-CD was adsorbed onto Ah03, extracted according to the method 
of Anton and Sayre (12], and measured spectrofluorometrically by the 
method of Rorsman et al (13]. y-GTP and tyrosinase were assayed 
respectively by the methods of Szasz (14] and Hamada and Mishima 
[15], while proteins were estimated using Folin-Cicalteau reagent (16]. 
RESULTS 
NaiO, Treatment of Intact Cells 
Treatment of B-16 melanoma cells with 1.2 mM sodium 
periodate resulted in a dramatic reduction of y-GTP activity as 
compared to nontreated and sham-treated controls (Table l). 
The NaiO, -treated cells did not recover fully their y-GTP 
activity even after 20 h of culture in MEM + 10% FCS. 
5-S-CD Secretion after NaiO, Treatment 
Even though the NaiO,-treated B-16 melanoma cells had not 
yet recovered their ectoenzyme y-GTP levels, there were no 
differences in the levels of 5-S-CD secreted into the medium by 
these cells as compared to nontreated and sham-treated cells 
(Table II) . Neither cystine-dependent nor glutathione-dopa-
dependent 5-S-CD genesis was inhibited after NaiO, treat-
ments. 
Subcellular Findings 
5-S-CD: Table III gives the subcellular distribution of 5-8-
CD in Greene's melanotic melanoma. SF contains the highest 
amounts of 5-S-CD, followed by NF and SGF. LGF, which 
contains most of the melanosomes, showed notably substantial 
amounts of this amino acid. 
y-GTP and tyrosinase (Table IV): It has been found that 
LGF 3, which contains mostly melanized melanosomes as seen 
by electron microscopy of the negative preparations, showed 
the high levels of tyrosinase but exhibited little y-GTP activity. 
LGF 2 containing most of the premelanosomes, LGF 1 contain-
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TABLE I. Inhibition of y-glutamyl transpeptidase of B -16 melanoma 
cells by sodium periodate at 0 and 20 h after culture 
No. 
1 
2 
3 
Description 
Nontreated" 
Sham treatedb 
NaiO, treated< 
y-GTP (mmol p-niLToaniline formed / 10 min/ mg 
protein) 
Oh 
0.8 
0.5 
0.025 
20 h after culture) 
1.0 
0.9 
0.05 
"Cells washed with PBS only. 
1
' Cells treated with PBS only at 4°C for 15 min. 
c Cells treated with 1.2 mM Nai04 in PBS for 15 min at 4°C. 
TABLE II. Secretion of 5-S-cysteinyldopa by B-16 melanoma cells in 
20 h of culture after sodium periodate treatment 
No. 
1 
2 
3 
Description 
Nontreated" 
Sham treatedb 
NaiO., treated< 
/.lg 5-S-CE/20 h 
In the absence of 
dopa and gluta-
thione 
1.82 
1.03 
1.03 
In the presence of 10-'• 
M dopa and glutathione 
5.86 
5.09 
4.93 
u-c Same as in Table I. 
TABLE III. Subcellular distribution of 5-S-cysteinyldopa in. Greene's 
melanotic melanoma 
Wt. of melanotic Fraction a 5-S-CD Percent 5-S-CD/ g melanotic mela-melanoma (g) (!'g) noma (!'g) 
NF 0.53 3.73 
LGF 0.32 2.24 
2.31 SGF 0.11 0.76 
SF 13.38 93.27 
6.20 
NF 6.53 11.88 
LGF 5.46 9.93 
4.24 SGF 6.75 12.28 
SF 36.21 65.88 
12.97 
NF 8.03 15.04 
LGF 0.75 1.40 
3.79 SGG 4.71 8.82 
SF 39.93 74.73 
14.08 
" NF, LGF, SGF, and SF stand for nuclear, large-granule, small-
granule, and soluble frac t ions, respectively. 
TABLE IV. Tyrosinase and y-glutamyl transpeptidase in. the 
melan.osomes of Greene's melanotic melanoma 
Fraction" 
SF 
SGF 
LGF 
LGF1 
LGF2 
LGF3 
Tyrosinase 
(t.E 475/ 10 min/ mg pro-
tein) 
0.55 
0.15 
2.17 
0.21 
0.84 
1.12 
" Abbreviations as in Table III. 
y-Giutamyl transpeptidase• (mmol p-nitroaniline formed /30 
min/ mg protein) 
0.81 
2.81 
3.01 
2.08 
0.93 
ND 
"This may include its ectoenzyme portion except for LGF 3. 
ing most of Golgi, GERL and coated vesicles, and SGF which 
contains plasma membranes and ribosomes possessed high 
levels of y-GTP activity. The high y-GTP activity especially of 
the SGF fractions is presumably also due to the presence of the 
ectoenzyme portion of this enzyme. 
DISCUSSION 
In 1975, Agrup et al [6] found that homogenates of melanoma 
and kidney are capable of converting glutathione-dopa to 5-8-
CD and that this conversion is inhibited by glutathione. Re-
cently we also have observed that high concentrations of glu-
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tathione inhibit dopa-glutathione-dependent 5-S-CD genesis in 
our melanoma cell culture system [7]. These findings suggest 
that enzymes involved in the metabolism of glutathione, such 
as y-GTP, are also involved in the conversion of glutathione-
dopa to 5-S-CD. Hu and Buxman [17] found y-GTP activity in 
growing, differentiating, and actively melanin-synthesizing ret-
inrl pigment cells of the Rhesus eye. Significantly, they could 
not discern any y-GTP activity in terminally differentiated 
status of the cultured retinal pigment cells which have lost the 
capacity to synthesize melanin. Again these findings suggest 
that in addition to its normal functions in gmwth and differ-
entiation, y-GTP plays a role in melanogenesis. Agrup et al [6] 
have proposed that within melanoma cells, y-GTP converts 
glutathione-dopa to cysteinylglycinedopa which is then con-
verted to 5-S-CD by an enzyme acting on the peptide bond. 
However, in a number of cells, y-GTP is found mainly as an 
ectoenzyme, whose active site faces the external medium rather 
than the cytoplasm [9]. In melanoma cells also, a large portion 
of y-GTP appears to be an ectoenzyme as revealed by the 
selective inhibition by sodium periodate treatment (Table I). 
Intact lymphocytes are known to undergo mitosis and growth 
in culture after sodium periodate treatments [9], while B-16 
melanoma cells after treatment not only grow but also actively 
produce melanin. • These fmdings suggest that on sodium per-
iodate treatment of intact cells, their internal physiology is 
minimally affected. Ultrastructural localization studies have 
revealed that in addition to plasma membranes, the intracel-
lular membrane system is also fairly rich in y-GTP [18]. In B-
16 melanoma cells as well, light microscopic examination has 
revealed that the cytoplasm is fairly rich in y-GTP activity 
[19]. However, whether the y-GTP present intracellularly rep-
resents merely an intermediate stage in the processing of this 
glycoprotein enzyme or is actually physiologically active re-
mains unknown. In the present study we have found that there 
are no significant variations in the amount of 5-S-CD secreted 
into the medium by sodium periodate-treated and nontreated 
cells (Table II). The fmding that dopa-glutathione-dependent 
5-S-CD genesis remains unaffected even when the cells have 
not regained their normal levels of plasma membrane y-GTP 
(Tables I, II), suggests that, at least in melanoma cells, the 
intracellular y-GTP is physiologically active. 
The subcellular site of 5-8-CD genesis is the next target to be 
clarified in order to understand pheomelanogenesis within 
mammalian pigment cells. Agrup et al [20] have suggested that 
5-S-CD synthesized within melanosomes is incorporated into 
melanin, whereas 5-S-CD synthesized in the cytoplasm is ex-
creted out. Thus two sites of 5-S-CD genesis are implied in 
their suggestion. 
Our present studies on the subcellular distribution of tyrosin-
ase and y-GTP reveal that tyrosinase and y-GTP may co-exist 
within premelanosomes (Table IV). These findings suggest that 
glutathione-dependent 5-S-CD genesis cannot take place within 
the premelanosomes. The other metabolic pathway involving 
the nonenzymic post-dopaquinone nucleophilic addition of cys-
teine to form 5-S-CD would then depend upon the availability 
of free cysteine within and/or in the vicinity of the melano-
somes. Although cysteine unlike glutathione is not freely avail-
able in most biologic materials [21], the reduction of cystine to 
cysteine may possibly occur as and when it is required. Since in 
vivo eu- and pheo-melanization proceeds only in premelano-
somes [22] through the formation of dopaquinone, it seems that 
either dopaquinone formed within the melanosome is released 
into the cytoplasm wherein glutathione-dopa is formed or glu-
tathione-dopa and further 5-S-CD are formed within the me-
lanosome the excess of which overflows into the cytoplasm and 
• Mojamdar M, Ichihashi M, Mishima Y: Sodium periodate induced 
hypermelanization of B-16 melanoma cells in vitro. 82nd Annual Gen-
eral Meeting of the Japanese Dermatological Association, Osaka, April 
3- 5, 1983. Submitted for presentation. 
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further in vivo into the urine. In either case, glutathione-dopa-
dependent 5-S-CD genesis occurs in the cytoplasm which is 
rich in y-GTP (Table IV). Further, the presence of high con-
centrations of 5-S-CD in the soluble fractions of both Greene's 
(Table III) and Harding-Passey melanoma [1] supports the 
present hypothesis of the overflow from the premelanosome. 
Concerning further conversion of 5-S-CD to pheomelanin where 
again tyrosinase is required, until the emergence of further 
evidence indicating that 5-S-CD formed from glutathione-dopa 
by the action of y-GTP in the cytoplasm is reavailable to the 
melanosome, only intrapremelanosomal 5-S-CD formation and 
its subsequent oxidation to pheomelanin ought be considered. 
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